Artificial intelligence accelerates drug discovery and reduces animal testing

1. Artificial intelligence is cutting preclinical development timelines from more than three years to under two years. 2. The Food and Drug Administration now supports validated computational models as part of regulatory submissions. On September 2, Reuters reported that the United States Food and Drug Administration is promoting artificial intelligence platforms that simulate drug safety